BP
ATRS

Ballentine Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Ballentine Partners’s Portfolio ATRS Stock Details ATRS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
2018
Q3 		$336K Hold
2018
Q2 		$258K Hold
2018
Q1 		$220K Hold
2017
Q4 		$199K Hold
2017
Q3 		$324K Hold
2017
Q2 		$318K Buy
2013
Q3 		– Sell
2013
Q2 		$499K Buy